In terms of Red Chip listing, Mr. Li has successfully advised the listing of Jinxin Fertility Group Limited, New Century Healthcare Holding Co. Limited, Harmonicare Medical Holdings Limited, Ascletis Pharma Inc., MicroPort Scientific Corporation, Weimob Inc., Midea Real Estate Holding Limited, DaFa Properties Group Limited, Optics Valley Union Holding Company Limited, Zhou Hei Ya International Holdings Company Limited, Yihai International Holding Ltd., Yadea Group Holdings Ltd., Honma Golf Limited, Koradior Holdings Limited, China Agri-Industries Holdings Limited, Tenwow International Holdings Limited, China Yongda Automobiles Services Holdings Limited, China Huirong Financial Holdings Limited, Chinalco Mining Corporation International, Dameng Mining Industries Ltd. and China Resources Cement.
In terms of H Share listing, Mr. Li has successfully advised the listing of CanSino Biologics Inc., Chanjet Information Technology Company Limited, Bank of Tianjin Co., Ltd., Zhongyuan Bank Co., Ltd., Holly Futures Co., Ltd., Guangzhou Automobile Group Co., Ltd., China International Marine Containers (Group) Co., Ltd., China Coal Holdings Limited, Huadian Fuxin Energy Corporation Limited, Metallurgical Corporation of China Ltd. and China Communications Construction Company Limited.
M&A and PE Investments：
Represented the management of Xiamen Qinhuai Technology Co., Ltd. along with Bain Capital in the management buy-out of Qinhuai Data and its subsidiaries and the merger of Qinhuai Data and Bridge Data Center in 2019 (the single largest IDC investment in China so far).
Represented China Ocean Shipping (Group) Company and China COSCO Shipping Corporation Limited in the landmark restructuring, comprising a series of asset acquisitions and disposals among its patent companies and its subsidiaries. The restructuring represents a substantial reconfiguration of two of China’s leading state-owned enterprises which, on a combined basis, will become the world’s fourth largest container-shipping company. This transaction was awarded “Deal of the Year 2016” by Asia Business Law Journal.
Represented Taikang Insurance Group in its acquisition of a 26.44% stake in Harmonicare Medical Holdings Limited, a Hong Kong-listed the largest private obstetrics and gynecology specialty hospital group based in China.
Represented SCPG Holdings Co., Ltd., a leading shopping mall owner, developer, and operator in China, China Vanke Co., Ltd., a leading urban and rural construction and residential service provider, and Triwater Asset Management Holdings Limited, in the formation of an offshore consortium for the purpose of acquiring a large-scale Chinese real estate portfolio from CapitaLand Mall Asia Limited, a wholly owned subsidiary of CapitaLand Limited, for RMB8.365 billion. The portfolio comprises of 20 shopping malls, with a total gross floor area of around 950,000 square meters, in locations across 19 cities in China.
Represented Strawbear Entertainment Group in its Pre-IPO investment in Taurus Holding Ltd., a subsidiary of iQIYI, with a total value of RMB270 million.
Represented XueBaJun, a leading internet education technology company in China, from its establishment of VIE structure all the way through five rounds of financing (Pre-A round to the C + round) with more than US$100 million.
Represented Green Tea Restaurant, a leading Chinese casual dining restaurant chain, in its financing from Partners Group, one of the world’s largest private equity investment companies.
Represented Ally Bridge Group, in its Series B investment into LinkDoc Technology Limited, a leading oncology big data company based in China, alongside other leading Chinese and international investors.
Represented HOPU Investment, in its formation of a strategic partnership with COFCO Meat, one of the largest hog producers in China, as one of the investors. HOPU Investments is a China-focused private equity firm with an international investment platform that has a focus on the consumer, natural resources, and financial services industries. The investor consortium also included KKR, Baring Private Equity Asia and Boyu Capital, which will invest in COFCO Meat alongside its existing shareholders to build and manage large-scale industrialized hog farms and meat processing plants in China.
Represented China Huarong Asset Management Co., Ltd. in its US$2.4 billion capital increase from a consortium of strategic investors, including China Life Insurance, Warburg Pincus, CITIC Securities International, Khazanah Nasional Berhad, China International Capital Corporation, COFCO, Fosun International and Goldman Sachs.
Represented Temasek Holdings’ US$150 million Series E round in Ai Wu Ji Wu (iwjw.com), an online platform offering house rental services in China.
Represented Digitalis Capital in its Series B round investment in Mollybox.
Represented Tenwow International Holdings Limited in several rounds of bidding PE investments and accepting offers from various PE investors.
Represented Guangzhou Auto, the fourth largest auto group in China, in its privatization of Denway Motors, a Hong Kong listed company. This transaction was awarded “M&A Deal of the Year 2011” by China Law & Practice, and “Best Domestic M&A Deal 2011” by FinanceAsia.
Represented Gorgeous Investments Limited in its US$172 million acquisition of 51.72% of share capital of China Smarter Energy Group Holdings Limited, a Hong Kong listed company, and tendering mandatory unconditional cash offer to acquire all issued shares.
Represented Massive Force Limited in its mandatory unconditional cash offer and acquire 74.10% issued shares in KFM Kingdom Holdings Limited.
Represented Nat-Ace Pharmaceutical in its US$35 million acquisition of 52.79% of the entire share capital of Perception Digital Holdings Limited. Pursuant to the Hong Kong Takeovers Code, CCB International Capital Limited for and on behalf of Nat-Ace Pharmaceutical has made an unconditional mandatory cash offer to acquire all the issued shares in and cancel all outstanding options of Perception Digital.
Represented CDH Investment as the subscriber in the HK$300,000,000 convertible bond issuance by Hong Kong-listed China Grand Pharmaceutical and Healthcare Holdings Limited, also in the US$25 million acquisition of up to 20% interest in Shanghai Weicon Optical Co. Ltd.
Represented New Lion Bridge Co., Ltd in the issuance of US$160 million guaranteed senior notes, guaranteed by its sole shareholders, Lionbridge Capital. Guotai Junan International, UBS, ICBC International and Zhongtai International were the underwriters.
History at the Firm
Nan Li is a senior partner of Tian Yuan Law Firm Hong Kong Office (in Association with William Ji & Co. LLP)(“TYHK”). Prior to joining TYHK, Mr. Li was a global partner and the chief representative of Beijing office of Paul Hastings LLP. Mr. Li has a broad range of corporate finance and mergers and acquisitions experience, with a focus on public and private securities offerings, cross border mergers and acquisitions and private equity investments. Mr. Li was recognized as a leading capital markets lawyer by The Legal 500 and IFLR 1000, and was regarded as “expert in finance and mergers and acquisitions”. Mr. Li was praised by the client to be “proficient in foreign and Chinese law, and has a deep understanding of customer business”, and is “a lawyer of sound judgment and great diligence and carefulness”. Mr. Li was admitted to practice in Hong Kong and New York.
University of Pennsylvania Law School, LL.M.
China University of Political Science and Law, LL.B.
More real-time news
Please pay attention to the Tianyuan law firm WeChat public account
Long according to QR code, automatic identification of QR code.